• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    State of the Industry Series (Part 1): FDA Restructuring and FTC Activity

    State of the Industry Part 2: Supplement Access, Safety, and CBD

    State of the Industry Part 3: Communication, Education, and Trust

    State of the Industry Part 4: Advanced/Advancing Technologies and Research

    State of the Industry Part 5: Advocating Best Practices
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier
    Exclusives
    Top Companies
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    Tocotrienol Supplementation May Aid Liver Function in Diabetes, MASL Patients

    Euromed Receives EcoVadis Platinum Medal for ESG Efforts

    State of the Industry Part 2: Supplement Access, Safety, and CBD
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Kyowa Hakko Publishes First Report on Global Health, Sustainability Impact
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Gencor’s PEA Ingredient Levagen+ May Offer Allergy Relief
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Aiya America, Inc. (Aiya Matcha)

    BGG World

    Kaneka Nutrients

    Bioenergy Life Science, Inc. (BLS)

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Aiya America, Inc. (Aiya Matcha)

    BGG World

    Kaneka Nutrients

    Bioenergy Life Science, Inc. (BLS)

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Top Companies
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Rough Road Ahead for Medical Foods?

    Recent FDA activity suggests increased scrutiny of the category and more aggressive enforcement.

    Rough Road Ahead for Medical Foods?
    Rough Road Ahead for Medical Foods?
    Gregory Stephens, RD, Windrose Partners11.01.13
    In the last Business Insights column I discussed a renewed convergence of the dietary supplement and pharmaceutical industries. This was a hot hallway topic at several recent conferences. The fact that pharmaceutical and consumer packaged goods (CPG) companies are once again investing in dietary supplement brands is something of a concern to supplement companies. The example often cited is Procter & Gamble’s acquisition of New Chapter. On the other hand, pharmaceutical companies have noted that the medical food business is being encroached upon by supplement companies, which appear anxious to enter this rapidly growing market. Such conversations are not new; the names and regulatory categories change but competiveness is a mainstay of our industry.

    There are several factors driving medical foods into the spotlight. Globally, it is a rapidly growing multibillion-dollar market. Secondly, through guidance documents and enforcement actions, FDA is beginning to raise concern about the viability of the market.

    FDA Enforcement Actions
    There has been much discussion over the past year about FDA tightening down on structure-function claims. A good example is the recent FDA enforcement activity around inflammation related claims. Sometimes out of frustration, dietary supplement company executives have suggested that going the medical food route may open new doors not accessible to dietary supplements. Not only can medical foods make “disease management” label claims, the classification may also elevate the perception of efficacy for their products.

    Most people in the industry are now aware of the basic definition of a medical food: Foods that help to manage a disease or condition by meeting the “distinctive nutritional requirements” that the disease or condition creates. For example, FDA pointed out that some inborn errors of metabolism like phenylketonuria (PKU) require considerable modification of the diet to avoid phenylalanine in order to avoid serious medical issues. It is difficult for PKU patients to achieve these dietary modifications, thus the need for medical foods to help manage the condition.

    For years the pharmaceutical medical food companies (e.g., Nestle and Abbott Nutrition) have walked a fine line with FDA on medical food requirements, yet not without occasional confrontation. However, over the past few years, supplement companies and start-ups have taken this opportunity to expand the indications for medical foods to a much broader range of diseases. I have commented before that many of these companies seem to be “flying under the FDA radar.”  That is, they do not present a significant enough threat to consumers to warrant the FDA’s attention, given their limited resources. Based on the agency’s actions over the past few months, it appears FDA is beginning to pay increasing attention to the category. FDA’s new draft Medical Foods Guidance Document and Q&As, as well as a number of recent warning letters disallowing medical food products, indicate the agency is determined to interpret the definition of medical food narrowly and prohibit the marketing of many novel products that might fit into this category.

    Recently, a major supplement company in the practitioner channel received a warning letter from FDA addressing several of its products marketed as medical foods. In the letter, FDA stated, “these products are labeled as ‘medical foods,’ and the labeling claims on your website represent these products as medical foods for the dietary management of a variety of medical conditions.”

    Based on the FDA review of the company’s website, it was determined that 14 of its medical food labeled products were misbranded, not meeting the statutory definition. Thus, FDA stated the claims made on these products cause them to be unapproved drugs.

    Key to FDA’s action are elements of the statutory definition of medical foods. Specifically, a medical food is “a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.” Also, a medical food must be intended for a patient who has a limited or impaired capacity to ingest, digest, absorb or metabolize ordinary foodstuffs or certain nutrients, or who has other special medically determined nutrient requirements, the dietary management of which cannot be achieved by modification of the normal diet alone.

    The warning letter references the company’s products that target numerous health conditions: chronic fatigue syndrome, fibromyalgia, leaky gut syndrome, metabolic syndrome and cardiovascular disease, inflammatory bowel conditions and/or inflammatory bowel disease, type 2 diabetes, atopic disorders such as eczema, rhinitis and allergy-responsive asthma, pre- and post-operative bariatric patients and peripheral artery disease.

    For these conditions, FDA stated it is not aware of any (not all apply to each indication):

    • Evidence that patients with these conditions have a limited or impaired capacity to ingest, digest, absorb or metabolize any specific nutrients;
    • Distinctive nutritional requirement for patients with these conditions…that cannot be met through dietary modification alone.

    Interestingly, for the bariatric product, FDA noted that a patient’s nutritional requirements can be met through dietary modification alone, “which may include use of a daily multi-vitamin.” Here we have the FDA suggesting use of a dietary supplement as a modification to the normal diet.

    Additionally, FDA noted the products are not Generally Recognized As Safe (GRAS) and effective for their referenced uses and, therefore, the products are “new drugs,” which cannot be legally introduced without prior approval from FDA. One of the unique differences between medical foods and dietary supplements is that ingredients in a medical food must be GRAS.

    FDA Draft Guidance and Q&A on Medical Foods
    The recently issued Medical Food Guidance/Q&A document will likely impact the development of these products. The majority of this guidance document appears quite similar to the 1996 “Regulation of Medical Foods: Advance Notice of Proposed Rulemaking (ANPR),” which was subsequently withdrawn by FDA in 2003 due to a “lack of activity, lack of resources, change in priorities”—though the agency stated the opinions expressed are still the same. The new guidance document reflects a renewed focus on this class of foods.

    In the most recent guidance document, FDA seems to take direct aim at what is currently the largest indication for medical foods: diabetes. The agency acknowledged there are distinctive nutritional requirements for patients with diabetes, but also stated it does not see type 1 or type 2 diabetes as conditions that require a medical food. FDA pointed out that a regular diet can be modified to meet the needs of patients with either type of diabetes. Certainly, FDA does not consider today’s consumers’ lifestyles, where adhering to a diabetic regimen may be much more realistic with convenient, healthy snacks and meal replacements.

    This invites the question: what about legacy products like Boost Glucose Control (Nestle) and Glucerna (Abbott Nutrition)? Both are labeled and marketed at retail with medical food claims. These brands are not small; collectively, estimated retail and institutional sales (e.g., hospitals and nursing homes) exceed $300 million annually in the U.S. alone.

    FDA points out that medical foods are necessary for select conditions. PKU being one where modification of the diet can possibly be achieved; however, that would be rather difficult. Where is the line to be drawn? How difficult must modification of the diet be for FDA to consider it appropriate to be a medical food?

    What’s Next?
    The Medical Food Guidance Document and recent warning letters suggest the category is being looked over closely, and it’s fair to expect more aggressive enforcement action. Still, for decades, very large pharmaceutical companies have invested heavily in research and development and promotion of medical foods.

    Thus, contrary to comments I’ve heard, the medical food category is not going away. It serves a valuable need for patients with some very serious health conditions. There are very reputable companies committed to developing new, innovative products in this billion-dollar industry. The challenge will be to continue funding research, including cost-benefit studies, and communicating with health practitioners, government agencies and Congress to protect the interests of patients who benefit from this much needed class of disease-management products.  


    Save the Date: The Second Annual Health Practitioner Market Forum, April 2-4, 2014, Hotel Maya – Long Beach, CA. Position your company for success in the health practitioner channel and the market for medical foods. Contact: Greg Stephens, 215-860-5186; E-mail: gregstephens@windrosepartners.com; Website: www.HPMForum.com.


    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 215-860-5186; E-mail: gregstephens@windrosepartners.com.
    Related Searches
    • Metabolic Syndrome
    • Dietary Supplement
    • Natural
    • Allergy
    Related Knowledge Center
    • Dietary Supplements
    • Healthcare Trends
    • Regulations
    • Medical Nutrition
    • Functional Foods & Beverages
    • Inflammation
    Suggested For You
    Reinforcing Omega-3 Supply Networks Reinforcing Omega-3 Supply Networks
    G-Agmatine: An Innovative Solution for a Healthy Nervous System G-Agmatine: An Innovative Solution for a Healthy Nervous System
    Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D
    Nutraceuticals Nutraceuticals
    Registered Dietitians in the Natural Products Industry: Friend or Foe? Registered Dietitians in the Natural Products Industry: Friend or Foe?
    ChromaDex Partners with MyPharma2Go for Brazilian Distribution ChromaDex Partners with MyPharma2Go for Brazilian Distribution
    Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms Medical Food Addresses Fatty Acid Deficiencies, May Help Manage ADHD Symptoms
    Guardion Inks Testing Agreement with OmegaQuant Guardion Inks Testing Agreement with OmegaQuant
    ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics ‘You Are What You Eat’ (Chapter 2): Nutrigenetics & Nutrigenomics
    Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    The Nuts and Bolts of FDA’s 2023 Budget Request The Nuts and Bolts of FDA’s 2023 Budget Request
    Lanfam LLC Launches Medical Food for Pain Relief Lanfam LLC Launches Medical Food for Pain Relief
    The Value of Clinical Evidence Supporting Nutraceuticals The Value of Clinical Evidence Supporting Nutraceuticals
    NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI NEM Eggshell Membrane Receives Novel Food Approval from India’s FSSAI
    Claims Spell Success in Today’s Nutritional Products Market Claims Spell Success in Today’s Nutritional Products Market

    Related Features

    • Reinforcing Omega-3 Supply Networks

      Reinforcing Omega-3 Supply Networks

      The status of the Peruvian anchovy fishery underscores the need to future-proof supplies of EPA, DHA, and other omega-3 fatty acids.
      By Mike Montemarano, Associate Editor 09.29.23

    • Dietary Supplements | Healthy Aging | Pet Nutraceuticals | Proteins, Peptides, Amino Acids
      G-Agmatine: An Innovative Solution for a Healthy Nervous System

      G-Agmatine: An Innovative Solution for a Healthy Nervous System

      Gad Gilad discusses the company’s research and its line of products that address challenges to healthy nerve function.
      By Sheldon Baker 05.01.23

    • Breaking News | Digestive Health | Medical Nutrition | Products | Proteins, Peptides, Amino Acids
      Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D

      Entrinsic Bioscience Expands Medical Food Line with enterade IBS-D

      Formula of amino acids and electrolytes supports digestive function while replenishing fluid loss and minerals.
      02.21.23


    • Nutraceuticals

      ...
      11.14.22

    • Dietary Supplements | Healthcare Trends | Medical Nutrition
      Registered Dietitians in the Natural Products Industry: Friend or Foe?

      Registered Dietitians in the Natural Products Industry: Friend or Foe?

      The natural products industry is evolving in many ways, with rapid growth and increased sales. Dietitians are playing a sizable role.
      By Greg Stephens, Windrose Partners and Sheila Campbell, PhD, RD 09.08.22

    Loading, Please Wait..
    Breaking News
    • Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    • FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    • MSM Linked to Improvements in Knee Pain
    • Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress
    • NutraShure Introduces SA3X as Exclusive US Supplier
    View Breaking News >
    CURRENT ISSUE

    December 2023

    • State of the Industry Series (Part 1): FDA Restructuring and FTC Activity
    • State of the Industry Part 2: Supplement Access, Safety, and CBD
    • State of the Industry Part 3: Communication, Education, and Trust
    • State of the Industry Part 4: Advanced/Advancing Technologies and Research
    • State of the Industry Part 5: Advocating Best Practices
    • State of the Industry Part 6: Business Trends and Innovation
    • Radicle Science Aims to Set New Trajectory for Healthcare with Modern Clinical Trial Model
    • How Can the Nutraceuticals Industry Empower More Women?
    • The Naturally Proud Network: Supporting Diversity, Equity, and Inclusion
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
    Peninsula Polymers Acquires New Distribution Center in Indiana
    PPG Completes COLORFUL COMMUNITIES Project in Shildon, UK
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    Everly Health Releases At-Home Collection Kidney Health Test
    Kenco Adds Two to its Life Sciences Division Team
    Contract Pharma

    Latest Breaking News From Contract Pharma

    FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
    Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
    Innovent Biologics, Synaffix Expand ADC Licensing Deal
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Christian Louboutin Taps Morgane Martini as Global Makeup Artist
    Shiseido Forms New Venture Fund
    The Biggest Beauty Trends of 2023 and 2024
    Happi

    Latest Breaking News From Happi

    Topical Testosterone Formulation for Chest Hair Growth
    New York City Is Hub for Cosmetic Chemistry Next Week
    Wet & Forget USA Recalls 2.7 Million Bottles of ‘Xtreme Reach’ Outdoor Mold & Mildew Stain Remover
    Ink World

    Latest Breaking News From Ink World

    Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
    BASF Commits to Scope 3.1 Emissions Targets
    Dantex and ACTEGA Partner on ECOLEAF
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Carter boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ginni Strikes Deal to Sell Spinning, Knitting Operations
    Campen Machinery Announces Patent Pending Status for Airlaid Trays
    Veocel Partners with Beauty and Feminine Care Brands in Asia Pacific
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
    Dr. Srikant Datar to Retire from Stryker's Board of Directors
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
    Ciena Invests in US Manufacturing with Flex
    Sitoo, SML Team Up to Enhance CX and Retail Operations

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login